Immune Modulators Have Mixed Results on COVID Pneumonia
In December of 2020, URMC researchers joined the large, national ACTIV-1 clinical trial testing whether immune modulator drugs can speed recovery for patients hospitalized with COVID. Though results are mixed, the trial provides many insights for future trials and pandemics.
Clinical Research Center’s Emergency Move Ensures Continuous Volunteer Care
The Clinical Research Center has temporarily moved operations to the Saunders Research Building.
New Feasibility Assessment Can Tell You What It Will Take to Run Your Clinical Trial
The Office of Clinical Research has rolled out a new feasibility assessment that University researchers can use to assess what it will take to run a proposed clinical trial as well as any relevant risks.
1
2